| 000 | 01678 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513045430.0 | ||
| 264 | 0 | _c19950307 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199502000-00014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBitran, J D | |
| 245 | 0 | 0 |
_aA phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGB. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cFeb 1995 |
||
| 300 |
_a67-70 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xtherapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aInterferon-gamma _xtherapeutic use |
| 650 | 0 | 4 |
_aLung Neoplasms _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGreen, M | |
| 700 | 1 | _aPerry, M | |
| 700 | 1 | _aHollis, D R | |
| 700 | 1 | _aHerndon, J E | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 18 _gno. 1 _gp. 67-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199502000-00014 _zAvailable from publisher's website |
| 999 |
_c7846599 _d7846599 |
||